Jane Wolstenholme BA MSc PhD
Research Interests
- Priority Setting
- Contingent Valuation
- Cancer Screening
- Modelling
- Cancer
Selected Bibliography
- Pluddemann Annette, Price Christopher P, Thompson Matthew, Wolstenholme Jane, and Heneghan Carl (2011) Primary care diagnostic technology update: point-of-care testing for glycosylated haemoglobin. Br J Gen Pract, 61(583):139-40.
- Rivero-Arias Oliver, Gray Alastair, and Wolstenholme Jane (2010) Burden of disease and costs of aneurysmal subarachnoid haemorrhage (aSAH) in the United Kingdom. Cost Eff Resour Alloc, 8:6.
- Rivero-Arias Oliver, Ouellet Melissa, Gray Alastair, Wolstenholme Jane, Rothwell Peter M, and Luengo-Fernandez Ramon (2010) Mapping the modified Rankin scale (mRS) measurement into the generic EuroQol (EQ-5D) health outcome. Med Decis Making, 30(3):341-54.
- Legood Rosa, Wolstenholme Jane, and Gray Alastair (2009) From cost-effectiveness information to decision-making on liquid-based cytology: Mind the gap. Health Policy, 89(2):193-200.
- Rivero-Arias O, Ouellet M, Gray A, Wolstenholme J, Rothwell P M, and Luengo-Fernandez R (2009) Mapping the Modified Rankin Scale (mRS) Measurement into the Generic EuroQol (EQ-5D) Health Outcome. Medical Decision Making.
| jane.wolstenholme@dph.ox.ac.uk | |
| Tel | +44 (0)1865 289 269 |
| Fax | +44 (0)1865 289 271 |
Biography
Jane Wolstenholme joined the Health Economics Research Centre in December 1998, having previously worked at the University of Nottingham . Her main research interests lie in the areas of economic evaluation and health technology assessment from applied and methodological perspectives. During 2005 she was engaged on projects in modelling cost-effectiveness of prostate cancer screening and cervical cancer screening; economic evaluation alongside a RCT for the treatment of subarachnoid aneurysm; assessing the usefulness of cost-effectiveness data in priority setting. She is currently co-supervising two PhD students and one research officer and involved with teaching the MSc in global health and the HERC Advanced Methods course. She is an Associate of the Oxford Institute for Ageing and a member of the Health Economics Futures Group. She is also involved with the Oxford Centre for Monitoring and Diagnosis in Primary Care (MaDOx)
